← Back to Search

Case management for Opioid Use Disorder (ConNECT Trial)

N/A
Waitlist Available
Led By Alia Al-Tayyib, PhD
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days from treatment initiation
Awards & highlights

ConNECT Trial Summary

This trial is testing an intervention to help people with opioid addiction stay in treatment at Denver Health.

Eligible Conditions
  • Opioid Use Disorder

ConNECT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days from treatment initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days from treatment initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention in treatment at 90 days

ConNECT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
dedicated case management
Group II: Usual careActive Control1 Intervention
usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Case management
2014
Completed Phase 3
~2990

Find a Location

Who is running the clinical trial?

Denver Health and Hospital AuthorityLead Sponsor
101 Previous Clinical Trials
400,295 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,300 Total Patients Enrolled
Alia Al-Tayyib, PhDPrincipal Investigator - Denver Health
Denver Health and Hospital Authority

Media Library

Case management Clinical Trial Eligibility Overview. Trial Name: NCT04797962 — N/A
Opioid Use Disorder Research Study Groups: Usual care, Intervention
Opioid Use Disorder Clinical Trial 2023: Case management Highlights & Side Effects. Trial Name: NCT04797962 — N/A
Case management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04797962 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an upper age limit for individuals to be considered for this research study?

"This clinical trial allows participants aged 18-99 to enroll, providing they meet all other criteria."

Answered by AI

Would I be eligible to join the experiment?

"To be considered for this trial, applicants must have a diagnosis of OUD and be between the ages of 18-99. The current target recruitment figure is 120 individuals."

Answered by AI

Are there any prospective openings in this research endeavor?

"According to data from clinicaltrials.gov, this medical trial is not currently recruiting patients, with the initial post date set at March 30th 2021 and an edit on March 28th 2022. Nonetheless, there are 535 other studies actively enrolling participants right now."

Answered by AI

Who else is applying?

What state do they live in?
Utah
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have been on suboxone and methadone and vivatrol I don’t feel it if helping.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder
Alia Al-Tayyib 2021. "Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04797962.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top